Vaxcyte Reports Second Quarter 2023 Financial Results and
-- Advanced Ongoing VAX-24 Phase 2 Infant Study to Second Stage, Dosing First New Participants in July 2023; Topline Data from Primary Immunization Series...
Source: globenewswire.com
Stay updated with breaking news from Application Clearance Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Advanced Ongoing VAX-24 Phase 2 Infant Study to Second Stage, Dosing First New Participants in July 2023; Topline Data from Primary Immunization Series...